First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...

Tezepelumab demonstrated rapid and sustained clinical improvements in nasal polyp burden and symptom control, with effects ...

The complete response (CR) rate at 1 month improved from 25% with single-fraction conformal 3D RT (3D-CRT) to 37% with SBRT, ...

Food allergy in children with atopic dermatitis is associated with an increased risk for asthma, allergic rhinitis, and ...

CEO Önal said Türk Telekom had a ‘spectacular’ start to the year, primarily driven by the maintained strength in fixed ...

Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug ...